Noninvasive markers for staging fibrosis in chronic delta hepatitis
Takyar, V., Surana, P., Kleiner, D. E., Wilkins, K., Hoofnagle, J. H., Liang, T. J., Heller, T., Koh, C.
Published in Alimentary pharmacology & therapeutics (01.01.2017)
Published in Alimentary pharmacology & therapeutics (01.01.2017)
Get full text
Journal Article
Complications of percutaneous liver biopsy with Klatskin needles: a 36‐year single‐centre experience
Takyar, V., Etzion, O., Heller, T., Kleiner, D. E., Rotman, Y., Ghany, M. G., Fryzek, N., Williams, V. H., Rivera, E., Auh, S., Liang, T. J., Hoofnagle, J. H., Koh, C.
Published in Alimentary pharmacology & therapeutics (01.03.2017)
Published in Alimentary pharmacology & therapeutics (01.03.2017)
Get full text
Journal Article
A phase 2 study exploring once daily dosing of ritonavir boosted lonafarnib for the treatment of chronic delta hepatitis – end of study results from the LOWR HDV-3 study
Koh, C, Surana, P, Han, T, Fryzek, N, Kapuria, D, Etzion, O, Takyar, V, Rotman, Y, Canales, R, Dahari, H, Yurdaydin, C, Glenn, J, Heller, T
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
Rates of and Factors Associated With Placebo Response in Trials of Pharmacotherapies for Nonalcoholic Steatohepatitis: Systematic Review and Meta-analysis
Han, Ma Ai Thanda, Altayar, Osama, Hamdeh, Shadi, Takyar, Varun, Rotman, Yaron, Etzion, Ohad, Lefebvre, Eric, Safadi, Rifaat, Ratziu, Vlad, Prokop, Larry J., Murad, Mohammad Hassan, Noureddin, Mazen
Published in Clinical gastroenterology and hepatology (01.03.2019)
Published in Clinical gastroenterology and hepatology (01.03.2019)
Get full text
Journal Article
Pharmacokinetics and pharmacodynamics modeling of ritonavir boosted lonafarnib therapy in HDV patients: A phase 2 LOWR HDV-3 study
Dubey, P., Koh, C., Surana, P., Uprichard, S., Han, M.A.T., Fryzek, N., Subramanya, G., Kapuria, D., Etzion, O., Takyar, V., Rotman, Y., Yurdaydin, C., Glenn, J., Cotler, S., Heller, T., Dahari, H.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
FRI-323 - Pharmacokinetics and pharmacodynamics modeling of ritonavir boosted lonafarnib therapy in HDV patients: A phase 2 LOWR HDV-3 study
Dubey, P., Koh, C., Surana, P., Uprichard, S., Han, M.A.T., Fryzek, N., Subramanya, G., Kapuria, D., Etzion, O., Takyar, V., Rotman, Y., Yurdaydin, C., Glenn, J., Cotler, S., Heller, T., Dahari, H.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
LBP-519 - A phase 2 study exploring once daily dosing of ritonavir boosted lonafarnib for the treatment of chronic delta hepatitis – end of study results from the LOWR HDV-3 study
Koh, C., Surana, P., Han, T., Fryzek, N., Kapuria, D., Etzion, O., Takyar, V., Rotman, Y., Canales, R., Dahari, H., Yurdaydin, C., Glenn, J., Heller, T.
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
Medical image of the week: collapse of the trachea
Guruguri, Prathima, Takyar, Varun, Campion, Janet, Klotz, Stephen, Factor, Factor
Published in Southwest journal of pulmonary & critical care (17.07.2013)
Published in Southwest journal of pulmonary & critical care (17.07.2013)
Get full text
Journal Article